An At-Risk Population Screening Program for Mucopolysaccharidoses by Measuring Urinary Glycosaminoglycans in Taiwan

An At-Risk Population Screening Program for Mucopolysaccharidoses by Measuring Urinary Glycosaminoglycans in Taiwan

Background: The mucopolysaccharidoses (MPSs) are a group of rare lysosomal storage disorders characterized by the accumulation of glycosaminoglycans (GAGs) and which eventually cause progressive damage to various tissues and organs. We developed a feasible MPS screening algorithm and established a c...

Full description

Bibliographic Details
Main Authors:	Hsiang-Yu Lin, Chung-Lin Lee, Yun-Ting Lo, Ru-Yi Tu, Ya-Hui Chang, Chia-Ying Chang, Pao Chin Chiu, Tung-Ming Chang, Wen-Hui Tsai, Dau-Ming Niu, Chih-Kuang Chuang, Shuan-Pei Lin
Format:	Article
Language:	English
Published:	MDPI AG 2019-10-01
Series:	Diagnostics
Subjects:	cross-specialty collaboration glycosaminoglycans high-risk screening liquid chromatography/tandem mass spectrometry mucopolysaccharidosis
Online Access:	https://www.mdpi.com/2075-4418/9/4/140

Similar Items

Mucopolysaccharidoses in northern Brazil: Targeted mutation screening and urinary glycosaminoglycan excretion in patients undergoing enzyme replacement therapy
by: Gustavo M. Viana, et al.
Published: (2011-01-01)

Functional independence of Taiwanese patients with mucopolysaccharidoses
by: Chung‐Lin Lee, et al.
Published: (2019-08-01)

Status of newborn screening and follow up investigations for Mucopolysaccharidoses I and II in Taiwan
by: Chih-Kuang Chuang, et al.
Published: (2018-05-01)

Establishment of Glycosaminoglycan Assays for Mucopolysaccharidoses
by: Shunji Tomatsu, et al.
Published: (2014-08-01)

Glaucoma in mucopolysaccharidoses
by: Weijing Kong, et al.
Published: (2021-07-01)

Relationships among Height, Weight, Body Mass Index, and Age in Taiwanese Children with Different Types of Mucopolysaccharidoses
by: Hsiang-Yu Lin, et al.
Published: (2019-10-01)

Survival and diagnostic age of 175 Taiwanese patients with mucopolysaccharidoses (1985–2019)
by: Hsiang-Yu Lin, et al.
Published: (2020-11-01)

The Interplay of Glycosaminoglycans and Cysteine Cathepsins in Mucopolysaccharidosis
by: Alexis David, et al.
Published: (2023-03-01)

Aortic Root Dilatation in Taiwanese Patients with Mucopolysaccharidoses and the Long-Term Effects of Enzyme Replacement Therapy
by: Hsiang-Yu Lin, et al.
Published: (2020-12-01)

Prenatal genetic testing, counseling and follow-up of 33 Egyptian pregnant females with history of mucopolysaccharidoses
by: Khaled R. Gaber, et al.
Published: (2015-04-01)

Glycosaminoglycans as Biomarkers for Mucopolysaccharidoses and Other Disorders
by: Paige C. Amendum, et al.
Published: (2021-08-01)

A 1‐year and 4‐month‐old child with mucopolysaccharidoses type II: A clinical case report from Ethiopia
by: Solomie Jebessa Deribessa, et al.
Published: (2021-11-01)

Cardiac Evaluation Using Two-Dimensional Speckle-Tracking Echocardiography and Conventional Echocardiography in Taiwanese Patients with Mucopolysaccharidoses
by: Hsiang-Yu Lin, et al.
Published: (2020-01-01)

Diagnosis of Mucopolysaccharidoses
by: Francyne Kubaski, et al.
Published: (2020-03-01)

Diagnosis of Mucopolysaccharidoses and Mucolipidosis by Assaying Multiplex Enzymes and Glycosaminoglycans
by: Nivethitha Arunkumar, et al.
Published: (2021-07-01)

The importance of the otorhinolaryngologic evaluation in mucopolysaccharidosis patients
by: Bicalho, Cibele Gomes, et al.
Published: (2011-07-01)

Nationwide Newborn Screening Program for Mucopolysaccharidoses in Taiwan and an Update of the “Gold Standard” Criteria Required to Make a Confirmatory Diagnosis
by: Chih-Kuang Chuang, et al.
Published: (2021-08-01)

Surgical Management of Valvular Heart Disease in Mucopolysaccharidoses: A Review of Literature
by: Barbara A. Rosser, et al.
Published: (2022-02-01)

Application of tandem mass spectrometry in the screening and diagnosis of mucopolysaccharidoses
by: Jing-Wen Li, et al.
Published: (2024-04-01)

Use of a commercial agarose gel for analysis of urinary glycosaminoglycans in mucopolysaccharidoses
by: Ana Carolina Breier, et al.

Neonatal Screening for MPS Disorders in Latin America: A Survey of Pilot Initiatives
by: Francyne Kubaski, et al.
Published: (2020-11-01)

Long-term galsulfase enzyme replacement therapy in Taiwanese mucopolysaccharidosis VI patients: A case series
by: Hsiang-Yu Lin, et al.
Published: (2016-06-01)

Evaluation of Multiple Methods for Quantification of Glycosaminoglycan Biomarkers in Newborn Dried Blood Spots from Patients with Severe and Attenuated Mucopolysaccharidosis-I
by: Zackary M. Herbst, et al.
Published: (2020-08-01)

Evaluation of Two Methods for Quantification of Glycosaminoglycan Biomarkers in Newborn Dried Blood Spots from Patients with Severe and Attenuated Mucopolysaccharidosis Type II
by: Zackary M. Herbst, et al.
Published: (2022-01-01)

Assessing the impact of the five senses on quality of life in mucopolysaccharidoses
by: Roberto Giugliani, et al.
Published: (2020-04-01)

Quantification of glycosaminoglycans using harmine extract from Peganum harmala L. in mucopolysaccharidoses researches
by: Houda El Fissi, et al.
Published: (2024-01-01)

Mucopolysaccharidoses Differential Diagnosis by Mass Spectrometry-Based Analysis of Urine Free Glycosaminoglycans—A Diagnostic Prediction Model
by: Francesca D’Avanzo, et al.
Published: (2023-03-01)

Natural progression of cardiac features and long-term effects of enzyme replacement therapy in Taiwanese patients with mucopolysaccharidosis II
by: Hsiang-Yu Lin, et al.
Published: (2021-02-01)

Electromyography in diagnostic of median nerve lesion in carpal tunnel syndrome of children with mucopolysaccharidoses
by: A. L. Kurenkov, et al.
Published: (2015-02-01)

Anesthesiological risks in mucopolysaccharidoses
by: Alessandra Moretto, et al.
Published: (2018-11-01)

The Unifying Hypothesis of Alzheimer’s Disease: Heparan Sulfate Proteoglycans/Glycosaminoglycans Are Key as First Hypothesized Over 30 Years Ago
by: Alan David Snow, et al.
Published: (2021-10-01)

Mucopolysaccharidosis type IV: report of 5 cases of Morquio Syndrome
by: Jorge Alejandro Cadena Arteaga, MD. MSP., et al.
Published: (2022-02-01)

Clinical ocular manifestations of Taiwanese patients with mucopolysaccharidoses VI (Maroteaux–Lamy syndrome)
by: Hsu-Ying Lin, et al.
Published: (2019-01-01)

Development of a newborn screening tool for mucopolysaccharidosis type I based on bivariate normal limits: Using glycosaminoglycan and alpha‐L‐iduronidase determinations on dried blood spots to predict symptoms
by: Thomas J. Langan, et al.
Published: (2020-03-01)

Calculation of continuous reference intervals for biological parameters exhibiting strong age‐dependent level changes: Its application to glycosaminoglycans and sialic acid in urine
by: Carlos Emilio Rodríguez, et al.
Published: (2024-11-01)

Results of 14-year-long Enzyme Replacement Therapy in a Patient with Mucopolysaccharidosis Type II: Clinical Case
by: Natalia V. Zhurkova, et al.
Published: (2023-01-01)

Mucopolysaccharidosis type II (Hunter syndrome) in a boy from the Republic of Serbia: A case report
by: Tubić-Vukajlović Jovana M., et al.
Published: (2023-01-01)

Atypical presentation of mucopolysaccharidosis type IVA
by: Eric T. Rush
Published: (2016-09-01)

Mucopolysaccharidoses: A rare cause for bilateral cloudy cornea
by: Jayshri Vipin Ekhar, et al.
Published: (2017-01-01)

Cardiac features and effects of enzyme replacement therapy in Taiwanese patients with Mucopolysaccharidosis IVA
by: Hsiang-Yu Lin, et al.
Published: (2018-08-01)